A carregar...
Market Share and Costs of Biologic Therapies for Inflammatory Bowel Disease in the United States
BACKGROUND: Real-world data quantifying the costs of increasing biologics use in inflammatory bowel disease (IBD) are unknown. AIM: To determine the outpatient IBD drug utilization trends, relative market share, and costs in the United States during a nine-year period. METHODS: The Truven MarketScan...
Na minha lista:
| Publicado no: | Aliment Pharmacol Ther |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5760274/ https://ncbi.nlm.nih.gov/pubmed/29164650 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/apt.14430 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|